Spyre Therapeutics Inc. (NASDAQ: SYRE) is 30.25% higher on its value in year-to-date trading and has touched a low of $8.43 and a high of $47.97 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SYRE stock was last observed hovering at around $27.81 in the last trading session, with the day’s gains setting it 0.22%.
Currently trading at $28.03, the stock is 7.73% and 4.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing 0.79% at the moment leaves the stock 0.93% off its SMA200. SYRE registered 111.03% gain for a year compared to 6-month gain of 7.39%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.40% loss in the last 1 month and extending the period to 3 months gives it a -12.57%, and is 5.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.15% over the week and 6.49% over the month.
Spyre Therapeutics Inc. (SYRE) has around 30 employees, a market worth around $1.42B and $0.00M in sales. Distance from 52-week low is 232.50% and -41.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-49.68%).
The EPS is expected to grow by 92.35% this year
The shares outstanding are 50.79M, and float is at 45.24M with Short Float at 17.78%.
